rs11164649

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001854.4(COL11A1):​c.2611-19A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.689 in 1,611,902 control chromosomes in the GnomAD database, including 392,228 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.59 ( 29725 hom., cov: 33)
Exomes 𝑓: 0.70 ( 362503 hom. )

Consequence

COL11A1
NM_001854.4 intron

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.346

Publications

21 publications found
Variant links:
Genes affected
COL11A1 (HGNC:2186): (collagen type XI alpha 1 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Mutations in this gene are associated with type II Stickler syndrome and with Marshall syndrome. A single-nucleotide polymorphism in this gene is also associated with susceptibility to lumbar disc herniation. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]
COL11A1 Gene-Disease associations (from GenCC):
  • Marshall syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Genomics England PanelApp
  • Stickler syndrome type 2
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Orphanet
  • fibrochondrogenesis 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • hearing loss, autosomal dominant 37
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fibrochondrogenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • autosomal recessive Stickler syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001854.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 1-102979123-T-G is Benign according to our data. Variant chr1-102979123-T-G is described in ClinVar as Benign. ClinVar VariationId is 258445.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.891 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001854.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL11A1
NM_001854.4
MANE Select
c.2611-19A>C
intron
N/ANP_001845.3
COL11A1
NM_080629.3
c.2647-19A>C
intron
N/ANP_542196.2P12107-2
COL11A1
NM_001190709.2
c.2494-19A>C
intron
N/ANP_001177638.1P12107-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL11A1
ENST00000370096.9
TSL:1 MANE Select
c.2611-19A>C
intron
N/AENSP00000359114.3P12107-1
COL11A1
ENST00000512756.5
TSL:1
c.2263-19A>C
intron
N/AENSP00000426533.1P12107-4
COL11A1
ENST00000635193.1
TSL:1
n.1943-19A>C
intron
N/AENSP00000489428.1A0A0U1RRA7

Frequencies

GnomAD3 genomes
AF:
0.590
AC:
89671
AN:
152008
Hom.:
29722
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.261
Gnomad AMI
AF:
0.886
Gnomad AMR
AF:
0.685
Gnomad ASJ
AF:
0.683
Gnomad EAS
AF:
0.913
Gnomad SAS
AF:
0.824
Gnomad FIN
AF:
0.698
Gnomad MID
AF:
0.617
Gnomad NFE
AF:
0.701
Gnomad OTH
AF:
0.620
GnomAD2 exomes
AF:
0.696
AC:
174342
AN:
250312
AF XY:
0.709
show subpopulations
Gnomad AFR exome
AF:
0.245
Gnomad AMR exome
AF:
0.693
Gnomad ASJ exome
AF:
0.666
Gnomad EAS exome
AF:
0.912
Gnomad FIN exome
AF:
0.698
Gnomad NFE exome
AF:
0.695
Gnomad OTH exome
AF:
0.691
GnomAD4 exome
AF:
0.699
AC:
1020949
AN:
1459776
Hom.:
362503
Cov.:
38
AF XY:
0.704
AC XY:
511359
AN XY:
726256
show subpopulations
African (AFR)
AF:
0.243
AC:
8133
AN:
33456
American (AMR)
AF:
0.689
AC:
30768
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.665
AC:
17373
AN:
26130
East Asian (EAS)
AF:
0.925
AC:
36715
AN:
39690
South Asian (SAS)
AF:
0.819
AC:
70567
AN:
86214
European-Finnish (FIN)
AF:
0.698
AC:
37233
AN:
53358
Middle Eastern (MID)
AF:
0.635
AC:
3661
AN:
5766
European-Non Finnish (NFE)
AF:
0.698
AC:
775220
AN:
1110178
Other (OTH)
AF:
0.684
AC:
41279
AN:
60306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
15284
30569
45853
61138
76422
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19582
39164
58746
78328
97910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.590
AC:
89687
AN:
152126
Hom.:
29725
Cov.:
33
AF XY:
0.597
AC XY:
44407
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.261
AC:
10818
AN:
41492
American (AMR)
AF:
0.685
AC:
10470
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.683
AC:
2369
AN:
3468
East Asian (EAS)
AF:
0.913
AC:
4714
AN:
5164
South Asian (SAS)
AF:
0.824
AC:
3976
AN:
4826
European-Finnish (FIN)
AF:
0.698
AC:
7391
AN:
10584
Middle Eastern (MID)
AF:
0.622
AC:
183
AN:
294
European-Non Finnish (NFE)
AF:
0.701
AC:
47646
AN:
67994
Other (OTH)
AF:
0.622
AC:
1314
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1588
3176
4765
6353
7941
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
742
1484
2226
2968
3710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.633
Hom.:
14154
Bravo
AF:
0.572
Asia WGS
AF:
0.807
AC:
2807
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
2
not provided (2)
-
-
1
Fibrochondrogenesis 1 (1)
-
-
1
Hearing loss, autosomal dominant 37 (1)
-
-
1
Marshall syndrome (1)
-
-
1
Stickler syndrome type 2 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
6.9
DANN
Benign
0.51
PhyloP100
0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs11164649;
hg19: chr1-103444679;
COSMIC: COSV62177130;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.